{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:45:04Z","timestamp":1775738704404,"version":"3.50.1"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuroscience.2024.11.073","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:43:41Z","timestamp":1732938221000},"page":"202-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Retinopathy in Parkinson\u2019s disease: A potential biomarker for early diagnosis and clinical assessment"],"prefix":"10.1016","volume":"565","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5252-1882","authenticated-orcid":false,"given":"Kaimin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zufeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.11.073_b0005","first-page":"1427","article-title":"Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography","volume":"4","author":"Aaker","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0010","article-title":"Retinal nerve fiber layer and macular thickness in Parkinson's disease patients","volume":"13","author":"Abd Hamid","year":"2021","journal-title":"Cureus."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0015","doi-asserted-by":"crossref","unstructured":"Ahn J, Lee JY, Kim TW, Yoon EJ, Oh S, Kim YK, Kim JM, Woo SJ, Kim KW, Jeon B. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease. Neurology. 2018;91:e1003-e1012.","DOI":"10.1212\/WNL.0000000000006157"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0020","article-title":"Advancing the frontier: neuroimaging techniques in the early detection and management of neurodegenerative diseases","volume":"16","author":"Akram","year":"2024","journal-title":"Cureus."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","article-title":"Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease","volume":"116","author":"Altinta\u015f","year":"2008","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp-2022-329342","article-title":"Structural and functional changes in the retina in Parkinson's disease","volume":"94","author":"Alves","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.kjms.2017.11.006","article-title":"Optical coherence tomography findings in Parkinson's disease","volume":"34","author":"Aydin","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10633-022-09887-7","article-title":"Evaluation of the visual system with visual evoked potential and optical coherence tomography in patients with idiopathic Parkinson's disease and withmultiple system atrophy","volume":"145","author":"Batum","year":"2022","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3109\/02713683.2014.894080","article-title":"The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease","volume":"39","author":"Bayhan","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","article-title":"Arizona Parkinson's Disease Consortium. Phosphorylated \u03b1-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects","volume":"571","author":"Beach","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0055","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/mds.25272","article-title":"Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations","volume":"27","author":"Bertrand","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuint.2006.08.001","article-title":"A rat model of Parkinsonism shows depletion of dopamine in the retina","volume":"50","author":"Biehlmaier","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.24182","article-title":"\u03b1-synuclein in the inner retina in parkinson disease","volume":"75","author":"Bodis-Wollner","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00702-017-1812-x","article-title":"Self-perception and determinants of color vision in Parkinson's disease","volume":"125","author":"Brandt","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0075","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3233\/JPD-212676","article-title":"Choroidal Thickness Correlates with Clinical and Imaging Metrics of Parkinson's Disease: A Pilot Study","volume":"11","author":"Brown","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02252659","article-title":"L-Dopa improves colour vision in Parkinson's disease","volume":"7","author":"B\u00fcttner","year":"1994","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp.53.2.114","article-title":"Simultaneous VEP and PERG investigations in early Parkinson's disease","volume":"53","author":"Calzetti","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0090","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/ijms25031689","article-title":"Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease","volume":"25","author":"Casciano","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jns.2015.05.007","article-title":"Characterization of retinal architecture in Parkinson's disease","volume":"355","author":"Chorostecki","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/08164622.2021.1984179","article-title":"Retinal imaging biomarkers of neurodegenerative diseases","volume":"105","author":"Christinaki","year":"2022","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","article-title":"Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies","volume":"64","author":"Chrysou","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/0004-282x-anp-2021-0134","article-title":"Optical coherence tomography in neurodegenerative disorders","volume":"80","author":"Cunha","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0115","article-title":"Synsvansker ved Parkinsons sykdom [Visual impairment in Parkinson\u2019s disease]","volume":"144","author":"Dalbro","year":"2024","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0120","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/ijms24054391","article-title":"The Role of Alpha-Synuclein Deposits in Parkinson's Disease: A Focus on the Human Retina","volume":"24","author":"Di Pippo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0125","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archneur.59.8.1249","article-title":"Progressive worsening of spatial and chromatic processing deficits in Parkinson disease","volume":"59","author":"Diederich","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12883-023-03373-6","article-title":"Retinal functional and structural changes in patients with Parkinson's disease","volume":"23","author":"Elanwar","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102280","article-title":"Optical coherence tomography as a potential surrogate marker of dopaminergic modulation across the life span","volume":"96","author":"Elmers","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.17116\/oftalma202414003159","article-title":"Opticheskaya kogerentnaya tomografiya v diagnostike rasseyannogo skleroza","volume":"140","author":"Fursova","year":"2024","journal-title":"Vestn. Oftalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0145","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1167\/iovs.13-13062","article-title":"Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity","volume":"55","author":"Garcia-Martin","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/jnnp.44.3.227","article-title":"Visual and auditory evoked responses in patients with Parkinson's disease","volume":"44","author":"Gawel","year":"1981","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0024-3205(88)90315-3","article-title":"Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates","volume":"43","author":"Ghilardi","year":"1988","journal-title":"Life Sci."},{"issue":"Suppl 5","key":"10.1016\/j.neuroscience.2024.11.073_b0160","first-page":"145","article-title":"Znaczenie wzrokowych potencja\u0142\u00f3w wywo\u0142anych (VEP) w diagnostyce choroby Parkinsona [Significance of visual evoked potentials (VEP) in the diagnosis of Parkinson disease]","volume":"37","author":"Go\u0142ab","year":"2003","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0013-4694(87)90032-0","article-title":"Alteration of visual evoked potentials and electroretinograms in Parkinson's disease","volume":"66","author":"Gottlob","year":"1987","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2012.02.085","article-title":"Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on retinal dopaminergic system in mice","volume":"515","author":"Hamilton","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0175","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jnnp-2023-331083","article-title":"Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson's disease","volume":"94","author":"Hannaway","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0180","first-page":"2473","article-title":"Decreased dopamine in the retinas of patients with Parkinson's disease","volume":"31","author":"Harnois","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0185","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s10792-018-0934-y","article-title":"Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson's disease","volume":"39","author":"Hasanov","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42466-024-00325-4","article-title":"German Parkinson\u2019s Guidelines Committee; Trenkwalder C. Diagnosis and treatment of Parkinso\u0144s disease (guideline of the German Society for Neurology)","volume":"6","author":"H\u00f6glinger","year":"2024","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0195","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1007\/s00415-020-10304-9","article-title":"Central retina changes in Parkinson's disease: a systematic review and meta-analysis","volume":"268","author":"Huang","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0200","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00415-020-10094-0","article-title":"The specific pattern of retinal nerve fiber layer thinning in Parkinson's disease: a systematic review and meta-analysis","volume":"268","author":"Huang","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0205","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/brainsci14090861","article-title":"The Neuroprotective and Anxiolytic Effects of Magnesium Sulfate on Retinal Dopaminergic Neurons in 6-OHDA-Induced Parkinsonian Rats: A Pilot Study","volume":"14","author":"Huang","year":"2024","journal-title":"Brain Sci."},{"issue":"14","key":"10.1016\/j.neuroscience.2024.11.073_b0210","article-title":"Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes","volume":"19","author":"Indrieri","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0215","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","article-title":"Retinal nerve fiber layer thinning in Parkinson disease","volume":"44","author":"Inzelberg","year":"2004","journal-title":"Vision Res."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0225","article-title":"Optical coherence tomography evaluation of choroidal structure changes in diabetic retinopathy patients: A systematic review and meta-analysis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front Med (lausanne)."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0230","doi-asserted-by":"crossref","first-page":"478","DOI":"10.18502\/jovr.v16i3.9442","article-title":"Macular Optical Coherence Tomography Imaging in Glaucoma","volume":"16","author":"Kamalipour","year":"2021","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100938","article-title":"Past, present and future role of retinal imaging in neurodegenerative disease","volume":"83","author":"Kashani","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0240","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/WNO.0000000000000240","article-title":"Correlation Between Structural and Functional Retinal Changes in Parkinson Disease","volume":"35","author":"Kaur","year":"2015","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25543","article-title":"Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease","volume":"29","author":"Lee","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0250","first-page":"521","article-title":"Liu C","volume":"54","author":"Li","year":"2015","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-019-0162-z","article-title":"Parkinson's disease in China: a forty-year growing track of bedside work","volume":"8","author":"Li","year":"2019","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106379","article-title":"Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease","volume":"190","author":"Liang","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.17116\/jnevro2018118062105","article-title":"Organ zreniia kak ob''ekt izucheniia narusheni\u012d kognitivnykh funktsi\u012d pri bolezni Parkinsona","volume":"118","author":"Litvinenko","year":"2018","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain-from eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JPD-171184","article-title":"Progressive Changes in the Retinal Structure of Patients with Parkinson's Disease","volume":"8","author":"Ma","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0280","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.parkreldis.2015.08.002","article-title":"Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease","volume":"21","author":"Mailankody","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0285","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4103\/0028-3886.349658","article-title":"Retinal Changes in Parkinson's Disease: A Longitudinal Follow-up Study","volume":"70","author":"Mailankody","year":"2022","journal-title":"Neurol. India"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.09.013","article-title":"Accelerated accumulation of retinal \u03b1-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease","volume":"121","author":"Mammadova","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-0716-1008-4_5","article-title":"Retina as a Model to Study In Vivo Transmission of \u03b1-Synuclein in the A53T Mouse Model of Parkinson's Disease","volume":"2224","author":"Mammadova","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101272","article-title":"Chromatic visual evoked potentials: A review of physiology, methods and clinical applications","volume":"101","author":"Marmoy","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0305","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1038\/s41598-020-66497-6","article-title":"\u03b1-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells","volume":"10","author":"Marrocco","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0310","first-page":"949","article-title":"Alpha synuclein gene expression profile in the retina of vertebrates","volume":"13","author":"Mart\u00ednez-Navarrete","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0315","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1167\/iovs.16-20025","article-title":"Visual Contrast Sensitivity in Early-Stage Parkinson's Disease","volume":"57","author":"Ming","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2024.11.073_b0320","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.parkreldis.2015.09.015","article-title":"A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease","volume":"22","author":"Miri","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0325","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/08820538.2017.1307423","article-title":"Evaluation of Choroidal and Retinal Thickness Changes in Parkinson's Disease Using Spectral Domain Optical Coherence Tomography","volume":"33","author":"Moschos","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5301\/EJO.2010.1318","article-title":"Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss","volume":"21","author":"Moschos","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0335","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mds.27728","article-title":"Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases","volume":"34","author":"Murueta-Goyena","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ana.25944","article-title":"Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease","volume":"89","author":"Murueta-Goyena","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41531-024-00637-x","article-title":"Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson's disease","volume":"10","author":"Murueta-Goyena","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0350","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/brainsci13081173","article-title":"Visual Dysfunction in Parkinson's Disease","volume":"13","author":"Nieto-Escamez","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0355","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/jnnp.49.11.1280","article-title":"Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects","volume":"49","author":"Nightingale","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-016-0346-z","article-title":"The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain","volume":"4","author":"Normando","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0365","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","article-title":"Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD)","volume":"131","author":"Nowacka","year":"2015","journal-title":"Doc. Ophthalmol."},{"issue":"133","key":"10.1016\/j.neuroscience.2024.11.073_b0370","first-page":"1","article-title":"update)","volume":"2016","author":"Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP; International Society for Clinical Electrophysiology of Vision. ISCEV standard for clinical visual evoked potentials","year":"2016","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0375","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mds.27392","article-title":"Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson's disease pathology severity","volume":"33","author":"Ortu\u00f1o-Lizar\u00e1n","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0380","doi-asserted-by":"crossref","unstructured":"Papagiouvannis G, Theodosis-Nobelos P, Rekka EA. A Review on Therapeutic Strategies against Parkinson's Disease: Current Trends and Future Perspectives. Mini Rev Med Chem. 2024. Online ahead of print.","DOI":"10.2174\/0113895575303788240606054620"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0385","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10633-023-09945-8","article-title":"Retinal dysfunction in Parkinson's disease-results of the extended protocol for photopic negative response (PHNR) full-field electroretinogram (ERG)","volume":"147","author":"Polat","year":"2023","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0390","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009658","article-title":"Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study","volume":"6","author":"Polo","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnimg.2024.1340754","article-title":"Structural changes in the retina as a potential biomarker in Parkinson's disease: an approach from optical coherence tomography","volume":"3","author":"Poveda","year":"2024","journal-title":"Front Neuroimaging."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.11.073_b0400","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/WNL.42.4.887","article-title":"Abnormalities in color vision and contrast sensitivity in Parkinson's disease","volume":"42","author":"Price","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0405","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5935\/0004-2749.20140061","article-title":"Applications of visual evoked potentials and Fourier-domain optical coherence tomography in Parkinson's disease: a controlled study","volume":"77","author":"Quagliato","year":"2014","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.533375","article-title":"Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease","volume":"11","author":"Rascun\u00e0","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0415","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3928\/0191-3913-19960501-04","article-title":"Ocular motility in Parkinson's disease","volume":"33","author":"Repka","year":"1996","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.parkreldis.2016.10.006","article-title":"Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease","volume":"34","author":"Ridder","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0425","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.25896","article-title":"Photoreceptor layer thinning in idiopathic Parkinson's disease","volume":"29","author":"Roth","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0430","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0435","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNO.0000000000000203","article-title":"Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration","volume":"35","author":"Sari","year":"2015","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0440","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bjophthalmol-2013-304152","article-title":"Retinal thinning and correlation with functional disability in patients with Parkinson's disease","volume":"98","author":"Satue","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0445","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1167\/iovs.16-20460","article-title":"Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease","volume":"58","author":"Satue","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0450","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/aian.AIAN_152_18","article-title":"Optical Coherence Tomography Findings in Patients of Parkinson's Disease: An Indian Perspective","volume":"21","author":"Sengupta","year":"2018","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0455","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000520726","article-title":"Prevalence of Parkinson's Disease in Adults Aged 65 Years and Older in China: A Multicenter Population-Based Survey","volume":"56","author":"Song","year":"2022","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0460","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1007\/s10571-023-01419-4","article-title":"Retinal Changes in Parkinson's Disease: A Non-invasive Biomarker for Early Diagnosis","volume":"43","author":"Subramaniam","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0465","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1038\/s41598-019-48388-7","article-title":"Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson's disease","volume":"9","author":"Sung","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0470","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.soin.2023.12.019","article-title":"Enjeux actuels autour de lamaladie de Parkinson","volume":"69","author":"Thezenas","year":"2024","journal-title":"Soins"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0475","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1038\/s41598-022-11495-z","article-title":"Characterization of retinal function and structure in the MPTP murine model of Parkinson's disease","volume":"12","author":"Tran","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1146979","article-title":"Retinal alpha-synuclein accumulation correlates with retinal dysfunction and structural thinning in the A53T mouse model of Parkinson's disease","volume":"17","author":"Tran","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0485","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/biomedicines12010130","article-title":"Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson's Disease","volume":"12","author":"Tran","year":"2024","journal-title":"Biomedicines."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0490","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JPD-230293","article-title":"Altered Outer Retinal Structure, Electrophysiology and Visual Perception in Parkinson's Disease","volume":"14","author":"Tran","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0495","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2415-12-54","article-title":"Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease","volume":"12","author":"Tsironi","year":"2012","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0500","article-title":"The Relationship between Visual-Evoked Potential and Optic Coherence Tomography and Clinical Findings in Parkinson Patients","volume":"2023","author":"Tuncer","year":"2023","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0505","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00415-018-9051-0","article-title":"Early ophthalmologic features of Parkinson's disease: a review of preceding clinical and diagnostic markers","volume":"266","author":"Turcano","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0510","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/ijo.IJO_1409_21","article-title":"Assessment of retinal manifestations of Parkinson's disease using spectral domain optical coherence tomography: A study in Indian eyes","volume":"70","author":"Verghese","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0515","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00702-018-1872-6","article-title":"In vivo exploration of retinal nerve fiber layer morphology in Parkinson's disease patients","volume":"125","author":"Visser","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0520","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson's disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0525","article-title":"Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0530","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.3390\/medicina59122114","article-title":"Optical Coherence Tomography (OCT): A Brief Look at the Uses and Technological Evolution of Ophthalmology","volume":"59","author":"Zeppieri","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0535","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.parkreldis.2020.11.025","article-title":"Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson's disease: A longitudinal study","volume":"82","author":"Zhang","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0540","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0545","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s40520-022-02211-y","article-title":"Quantitative analysis of related parameters of retinal nerve fiber layer and ganglion cell complex thickness in patients with different degrees of Parkinson's disease","volume":"34","author":"Zhao","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0550","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000527372","article-title":"Burden of Parkinson Disease in China, 1990-2019: Findings from the 2019 Global Burden of Disease Study","volume":"57","author":"Zheng","year":"2023","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neuroscience.2024.11.073_b0555","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41531-023-00611-z","article-title":"Mendelian randomization reveals association between retinal thickness and non-motor symptoms of Parkinson's disease","volume":"9","author":"Zhou","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2024.11.073_b0560","doi-asserted-by":"crossref","unstructured":"Zhu J, Cui Y, Zhang J, Yan R, Su D, Zhao D, Wang A, Feng T. Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev. 2024;5:e464-e479.","DOI":"10.1016\/S2666-7568(24)00094-1"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224006924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224006924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T01:43:18Z","timestamp":1736214198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224006924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":112,"alternative-id":["S0306452224006924"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.073","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinopathy in Parkinson\u2019s disease: A potential biomarker for early diagnosis and clinical assessment","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}